Consumer, Patient Advocates Tell Congress Not To Shrink 340B Program

By Michelle M. Stein / May 14, 2018 at 6:52 PM

About 60 patient and consumer advocates told House and Senate leadership to reject proposals to cut back the number of patients and safety net providers that are eligible for the 340B drug discount program, though the groups say they support transparency in the program.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.